Trials / Conditions / Resistance to Immunotherapy
Resistance to Immunotherapy
4 registered clinical trials studyying Resistance to Immunotherapy — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ivarmacitinib Combined With Camrelizumab and Apatinib for Unresectable Advanced Hepatocellular Carcinoma With NCT07324473 | First Affiliated Hospital of Chongqing Medical University | Phase 2 |
| Not Yet Recruiting | Sintilimab Plus Anlotinib as Second or Further-line Therapy for ES-SCLC Who Have Progressed After Anti-PD-1/L1 NCT07022301 | First Affiliated Hospital of Wannan Medical College | Phase 2 |
| Not Yet Recruiting | PD-1 Combined With Bevacizumab and PCSK-9 Inhibitor in Patients With Advanced NSCLC Who Have Progressed After NCT07014215 | Anhui Provincial Cancer Hospital | Phase 2 |
| Active Not Recruiting | Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors NCT06076135 | Chuangzhen Chen | Phase 2 |